Want to see GB:FAB full AI Analyst Report?
Fusion Antibodies Plc (FAB) Income Statement
Fusion Antibodies Plc Income Statement
Last quarter (Q4 2025), Fusion Antibodies Plc's total revenue was $1.27M, an increase of 113.78% from the same quarter last year. In Q4, Fusion Antibodies Plc's net income was $-637.00K. See Fusion Antibodies Plc’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| $ 2.11M | $ 1.97M | $ 1.14M | $ 2.90M | $ 4.80M | |
| $ 1.10M | $ 430.00K | $ -265.00K | $ 202.00K | $ 1.72M | |
| $ 3.08M | $ 2.21M | $ 2.24M | $ 3.04M | $ 3.05M | |
| Depreciation and Amortization | $ 127.00K | $ 105.00K | $ 220.00K | $ 372.00K | $ 751.00K |
| $ -1.85M | $ -1.62M | $ -2.06M | $ -2.48M | $ -573.00K | |
| $ -1.98M | $ -1.78M | $ -2.29M | $ -2.83M | $ -1.33M | |
| $ 832.00K | $ 2.00K | $ -1.00K | $ -1.00K | $ -8.00K | |
| $ -1.15M | $ -1.78M | $ -2.29M | $ -2.86M | $ -1.33M | |
| $ -1.15M | $ -1.71M | $ -2.23M | $ -2.60M | $ -1.20M | |
| Per Share Metrics | |||||
| Basic EPS | $ -0.01 | $ -0.02 | $ -0.04 | $ -0.10 | $ -0.05 |
| Diluted EPS | $ -0.01 | $ -0.02 | $ -0.04 | $ -0.10 | $ -0.05 |
| Weighted Average Shares Outstanding | 115.31M | 95.88M | 55.56M | 26.01M | 25.95M |
| Weighted Average Shares Outstanding (Diluted) | 115.31M | 95.88M | 55.56M | 26.01M | 25.95M |
Currency in GBP
